Semin Musculoskelet Radiol 2018; 22(02): 166-179
DOI: 10.1055/s-0038-1639473
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Musculoskeletal Manifestations of Non-RA Connective Tissue Diseases: Scleroderma, Systemic Lupus Erythematosus, Still's Disease, Dermatomyositis/Polymyositis, Sjögren's Syndrome, and Mixed Connective Tissue Disease

Thibaut Jacques
1   Department of Musculoskeletal Radiology, University Hospital of Lille, Lille Cedex, France
2   Lille Medical School, University of Lille, Lille, France
,
Iwona Sudoł-Szopińska
3   Department of Radiology, National Institute of Geriatrics, Rheumatology and Rehabilitation; Warsaw, Poland
,
Neal Larkman
4   Harrogate District Hospital, Harrogate, United Kingdom
,
Phil O'Connor
5   Leeds NIHR Biomedical Research Centre, Leeds Teaching Hospitals, University of Leeds, Leeds, United Kingdom
,
Anne Cotten
1   Department of Musculoskeletal Radiology, University Hospital of Lille, Lille Cedex, France
2   Lille Medical School, University of Lille, Lille, France
› Author Affiliations
Further Information

Publication History

Publication Date:
19 April 2018 (online)

Abstract

The most common systemic rheumatologic conditions are connective tissue diseases (including rheumatoid arthritis [RA]) followed by spondyloarthropathy. With the advent of biotherapies and imaging biomarkers, development in the imaging of RA and spondyloarthropathies has received substantial attention in the literature. This article details the various musculoskeletal imaging features of the other connective tissue diseases such as scleroderma and progressive systemic sclerosis, systemic lupus erythematosus, Still's disease, dermatomyositis and polymyositis, Sjögren's syndrome, and mixed connective tissue disease.

 
  • References

  • 1 Elhai M, Avouac J, Kahan A, Allanore Y. Systemic sclerosis: recent insights. Joint Bone Spine 2015; 82 (03) 148-153
  • 2 Boonstra M, Huizinga TWJ, de Vries-Bouwstra JK. Auto-antibodies and cancer in systemic sclerosis. Autoimmun Rev 2017; 16 (08) 883-884
  • 3 Ferreli C, Gasparini G, Parodi A, Cozzani E, Rongioletti F, Atzori L. Cutaneous manifestations of scleroderma and scleroderma-like disorders: a comprehensive review. Clin Rev Allergy Immunol 2017; 53 (03) 306-336
  • 4 van den Hoogen F, Khanna D, Fransen J. , et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League Against Rheumatism Collaborative initiative. Ann Rheum Dis 2013; 72 (11) 1747-1755
  • 5 Avouac J, Walker UA, Hachulla E. , et al; EUSTAR collaborators*; EUSTAR collaborators. Joint and tendon involvement predict disease progression in systemic sclerosis: a EUSTAR prospective study. Ann Rheum Dis 2016; 75 (01) 103-109
  • 6 Jaeger VK, Distler O, Maurer B. , et al. Functional disability and its predictors in systemic sclerosis: a study from the DeSScipher project within the EUSTAR group. Rheumatology (Oxford) 2017; May 11 (Epub ahead of print)
  • 7 Chitale S, Ciapetti A, Hodgson R. , et al. Magnetic resonance imaging and musculoskeletal ultrasonography detect and characterize covert inflammatory arthropathy in systemic sclerosis patients with arthralgia. Rheumatology (Oxford) 2010; 49 (12) 2357-2361
  • 8 Bassett LW, Blocka KL, Furst DE, Clements PJ, Gold RH. Skeletal findings in progressive systemic sclerosis (scleroderma). AJR Am J Roentgenol 1981; 136 (06) 1121-1126
  • 9 Boutry N, Hachulla E, Zanetti-Musielak C, Morel M, Demondion X, Cotten A. Imaging features of musculoskeletal involvement in systemic sclerosis. Eur Radiol 2007; 17 (05) 1172-1180
  • 10 Schanz S, Fierlbeck G, Ulmer A. , et al. Localized scleroderma: MR findings and clinical features. Radiology 2011; 260 (03) 817-824
  • 11 Ngo S, Vandhuick T, Janvresse A, Levesque H, Marie I. Pseudotumoral calcinosis [in French]. Rev Med Interne 2011; 32 (04) 251-252
  • 12 Madani G, Katz RD, Haddock JA, Denton CP, Bell JR. The role of radiology in the management of systemic sclerosis. Clin Radiol 2008; 63 (09) 959-967
  • 13 Botou A, Bangeas A, Alexiou I, Sakkas LI. Acro-osteolysis. Clin Rheumatol 2017; 36 (01) 9-14
  • 14 Elhai M, Guerini H, Bazeli R. , et al. Ultrasonographic hand features in systemic sclerosis and correlates with clinical, biologic, and radiographic findings. Arthritis Care Res (Hoboken) 2012; 64 (08) 1244-1249
  • 15 Low AHL, Lax M, Johnson SR, Lee P. Magnetic resonance imaging of the hand in systemic sclerosis. J Rheumatol 2009; 36 (05) 961-964
  • 16 Allanore Y, Seror R, Chevrot A, Kahan A, Drapé JL. Hand vascular involvement assessed by magnetic resonance angiography in systemic sclerosis. Arthritis Rheum 2007; 56 (08) 2747-2754
  • 17 Resnick D, Greenway G, Vint VC, Robinson CA, Piper S. Selective involvement of the first carpometacarpal joint in scleroderma. AJR Am J Roentgenol 1978; 131 (02) 283-286
  • 18 Berth-Jones J, Coates PA, Graham-Brown RA, Burns DA. Neurological complications of systemic sclerosis—a report of three cases and review of the literature. Clin Exp Dermatol 1990; 15 (02) 91-94
  • 19 La Paglia GMC, Leone MC, Lepri G. , et al. One year in review 2017: systemic lupus erythematosus. Clin Exp Rheumatol 2017; 35 (04) 551-561
  • 20 Haute Autorité de Santé. Protocole National de Diagnostic et de Soins (PNDS): Lupus systémique. Available at: https://www.has-sante.fr/portail/jcms/c_2751894/fr/lupus-systemique . Updated 2017
  • 21 Ben-Menachem E. Review article: systemic lupus erythematosus: a review for anesthesiologists. Anesth Analg 2010; 111 (03) 665-676
  • 22 Pons-Estel GJ, Ugarte-Gil MF, Alarcón GS. Epidemiology of systemic lupus erythematosus. Expert Rev Clin Immunol 2017; 13 (08) 799-814
  • 23 Lahita RG. The connective tissue diseases and the overall influence of gender. Int J Fertil Menopausal Stud 1996; 41 (02) 156-165
  • 24 Simard JF, Costenbader KH. What can epidemiology tell us about systemic lupus erythematosus?. Int J Clin Pract 2007; 61 (07) 1170-1180
  • 25 Barbhaiya M, Costenbader KH. Ultraviolet radiation and systemic lupus erythematosus. Lupus 2014; 23 (06) 588-595
  • 26 Lowe GC, Henderson CL, Grau RH, Hansen CB, Sontheimer RD. A systematic review of drug-induced subacute cutaneous lupus erythematosus. Br J Dermatol 2011; 164 (03) 465-472
  • 27 Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40 (09) 1725-1725
  • 28 Zoma A. Musculoskeletal involvement in systemic lupus erythematosus. Lupus 2004; 13 (11) 851-853
  • 29 Piga M, Congia M, Gabba A. , et al. Musculoskeletal manifestations as determinants of quality of life impairment in patients with systemic lupus erythematosus. Lupus 2018; 27 (02) 190-198
  • 30 Tani C, D'Aniello D, Possemato N. , et al. MRI pattern of arthritis in systemic lupus erythematosus: a comparative study with rheumatoid arthritis and healthy subjects. Skeletal Radiol 2015; 44 (02) 261-266
  • 31 Tani C, D'Aniello D, Delle Sedie A. , et al. Rhupus syndrome: assessment of its prevalence and its clinical and instrumental characteristics in a prospective cohort of 103 SLE patients. Autoimmun Rev 2013; 12 (04) 537-541
  • 32 Piga M, Saba L, Gabba A. , et al. Ultrasonographic assessment of bone erosions in the different subtypes of systemic lupus erythematosus arthritis: comparison with computed tomography. Arthritis Res Ther 2016; 18 (01) 222
  • 33 Lalani TA, Kanne JP, Hatfield GA, Chen P. Imaging findings in systemic lupus erythematosus. Radiographics 2004; 24 (04) 1069-1086
  • 34 Nevskaya T, Gamble MP, Pope JE. A meta-analysis of avascular necrosis in systemic lupus erythematosus: prevalence and risk factors. Clin Exp Rheumatol 2017; 35 (04) 700-710
  • 35 Oh SN, Jee WH, Cho SM. , et al. Osteonecrosis in patients with systemic lupus erythematosus: MR imaging and scintigraphic evaluation. Clin Imaging 2004; 28 (04) 305-309
  • 36 Castro TCM, Lederman H, Terreri MTA, Caldana WI, Kaste SC, Hilário MO. The use of joint-specific and whole-body MRI in osteonecrosis: a study in patients with juvenile systemic lupus erythematosus. Br J Radiol 2011; 84 (1003): 621-628
  • 37 Tung Chen Y, Isenberg D. Necrotising fasciitis in systemic lupus erythematosus: a case report and literature review. Lupus Sci Med 2014; 1 (01) e000008
  • 38 Meesiri S. Pyomyositis in a patient with systemic lupus erythaematosus and a review of the literature. BMJ Case Rep 2016; ; April 28. DOI: 10.1136/bcr-2016-214809.
  • 39 Chander S, Gordon P. Soft tissue and subcutaneous calcification in connective tissue diseases. Curr Opin Rheumatol 2012; 24 (02) 158-164
  • 40 Egol KA, Jazrawi LM, DeWal H, Su E, Leslie MP, Di Cesare PE. Orthopaedic manifestations of systemic lupus erythematosus. Bull Hosp Jt Dis 2001; 60 (01) 29-34
  • 41 Sierra-Jimenez G, Sanchez-Ortiz A, Aceves-Avila FJ, Hernandez-Rios G, Durán-Barragán S, Ramos-Remus C. Tendinous and ligamentous derangements in systemic lupus erythematosus. J Rheumatol 2008; 35 (11) 2187-2191
  • 42 Nakamura K, Tajima Y, Takai O. Generalized laxity of connective tissue as a possible syndrome in systemic lupus erythematosus. Mod Rheumatol 2010; 20 (05) 522-527
  • 43 Ohta A, Yamaguchi M, Tsunematsu T. , et al. Adult Still's disease: a multicenter survey of Japanese patients. J Rheumatol 1990; 17 (08) 1058-1063
  • 44 Pay S, Türkçapar N, Kalyoncu M. , et al; Ankara Rheumatology Study Group. A multicenter study of patients with adult-onset Still's disease compared with systemic juvenile idiopathic arthritis. Clin Rheumatol 2006; 25 (05) 639-644
  • 45 Bywaters EG. Still's disease in the adult. Ann Rheum Dis 1971; 30 (02) 121-133
  • 46 Pouchot J. Maladie de Still de l'adulte. Rev Med Suisse 2008; 4: 1039-1044
  • 47 Efthimiou P, Paik PK, Bielory L. Diagnosis and management of adult onset Still's disease. Ann Rheum Dis 2006; 65 (05) 564-572
  • 48 Ichida H, Kawaguchi Y, Sugiura T. , et al. Clinical manifestations of adult-onset Still's disease presenting with erosive arthritis: association with low levels of ferritin and interleukin-18. Arthritis Care Res (Hoboken) 2014; 66 (04) 642-646
  • 49 Lilleker JB, Vencovsky J, Wang G. , et al; all EuroMyositis contributors. The EuroMyositis registry: an international collaborative tool to facilitate myositis research. Ann Rheum Dis 2018; 77 (01) 30-39
  • 50 Corral-Magaña O, Bauzá-Alonso AF, Escudero-Góngora MM, Lacruz L, Martín-Santiago A. Juvenile dermatomyositis: key roles of muscle magnetic resonance imaging and early aggressive treatment. Actas Dermosifiliogr 2017; September 11 (Epub ahead of print)
  • 51 Ramos-Casals M, Brito-Zerón P, Sisó-Almirall A, Bosch X. Primary Sjogren syndrome. BMJ 2012; 344: e3821
  • 52 Hajiabbasi A, Shenavar Masooleh I, Alizadeh Y, Banikarimi AS, Ghavidel Parsa P. Secondary Sjogren's syndrome in 83 patients with rheumatoid arthritis. Acta Med Iran 2016; 54 (07) 448-453
  • 53 Hatron P-Y. Syndrome de Gougerot-Sjögren. EMC Traité Médecine AKOS 2010; 5 (02) 1-6
  • 54 Vitali C, Bombardieri S, Jonsson R. , et al; European Study Group on Classification Criteria for Sjögren's Syndrome. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002; 61 (06) 554-558
  • 55 Iagnocco A, Modesti M, Priori R. , et al. Subclinical synovitis in primary Sjögren's syndrome: an ultrasonographic study. Rheumatology (Oxford) 2010; 49 (06) 1153-1157
  • 56 Shuckett R, Russell ML, Gladman DD. Atypical erosive osteoarthritis and Sjögren's syndrome. Ann Rheum Dis 1986; 45 (04) 281-288
  • 57 Ballard M, Meyer O, Adle-Biassette H, Grossin M. Jaccoud's arthropathy with vasculitis and primary Sjögren's syndrome. A new entity. Clin Exp Rheumatol 2006; 24 (02) (Suppl. 41) S102-S103
  • 58 Sharp GC, Irvin WS, Tan EM, Gould RG, Holman HR. Mixed connective tissue disease—an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med 1972; 52 (02) 148-159
  • 59 Ungprasert P, Crowson CS, Chowdhary VR, Ernste FC, Moder KG, Matteson EL. Epidemiology of mixed connective tissue disease, 1985–2014: a population-based study. Arthritis Care Res (Hoboken) 2016; 68 (12) 1843-1848
  • 60 Ciang NCO, Pereira N, Isenberg DA. Mixed connective tissue disease—enigma variations?. Rheumatology (Oxford) 2017; 56 (03) 326-333